West German Study PlanB Trial: Adjuvant Four Cycles of Epirubicin and Cyclophosphamide Plus Docetaxel Versus Six Cycles of Docetaxel and Cyclophosphamide in HER2-Negative Early Bre... von Nitz, Ulrike, Gluz, Oleg, Clemens, Michael, Malter, Wolfram, Reimer, Toralf, Nuding, Benno, Aktas, Bahriye, Stefek, Andrea, Pollmanns, Anke, Lorenz-Salehi, Fatemeh, Uleer, Christoph, Krabisch, Petra, Kuemmel, Sherko, Liedtke, Cornelia, Shak, Steven, Wuerstlein, Rachel, Christgen, Matthias, Kates, Ronald E, Kreipe, Hans H, Harbeck, Nadia

Volltext

Ruddy turnstones Arenaria interpres rapidly build pectoral muscle after raptor scares von J. van den Hout, Piet, Piersma, Theunis, Dekinga, Anne, K. Lubbe, Suzanne, Henk Visser, G.

Volltext

Effect of dairy farm management on Swallow Hirundo rustica abundance in The Netherlands von Lubbe, Suzanne K., de Snoo, Geert R.

Volltext

Characteristics of patients with brain metastases from human epidermal growth factor receptor 2-positive breast cancer: subanalysis of Brain Metastases in Breast Cancer Registry von Laakmann, E., Witzel, I., Neunhöffer, T., Park-Simon, T.-W., Weide, R., Riecke, K., Polasik, A., Schmidt, M., Puppe, J., Mundhenke, C., Lübbe, K., Hesse, T., Thill, M., Zahm, D.-M., Denkert, C., Fehm, T., Nekljudova, V., Rey, J., Loibl, S., Müller, V.

Volltext

Anti-hormonal maintenance treatment with or without the CDK4/6 inhibitor ribociclib after first line chemotherapy in hormone receptor positive/HER2 negative metastatic breast cance... von Decker, T., Denkert, C., Lübbe, K., Müller, V., Mundhenke, C., Furlanetto, J., Schmidt, M., Thill, M., Tierbach, V., Seither, F., Loibl, S.

Volltext

A multicentre, randomised, double-blind, phase II study to evaluate the tolerability of an induction dose escalation of everolimus in patients with metastatic breast cancer (DESIRE... von Schmidt, M., Lübbe, K., Decker, T., Thill, M., Bauer, L., Müller, V., Link, T., Furlanetto, J., Reinisch, M., Mundhenke, C., Hoffmann, O., Zahn, M.-O., Müller, L., Denkert, C., van Mackelenbergh, M., Fasching, P.A., Burchardi, N., Nekljudova, V., Loibl, S.

Volltext

Long-term survival of breast cancer patients with brain metastases: subanalysis of the BMBC registry von Riecke, K., Müller, V., Neunhöffer, T., Park-Simon, T.-W., Weide, R., Polasik, A., Schmidt, M., Puppe, J., Mundhenke, C., Lübbe, K., Hesse, T., Thill, M., Wuerstlein, R., Denkert, C., Decker, T., Fehm, T., Nekljudova, V., Rey, J., Loibl, S., Laakmann, E., Witzel, I.

Volltext

Economic aspects of cervical cancer screening von Koopmanschap, Marc A., Lubbe, Koos Th.N., van Oortmarssen, Gerrit J., van Agt, Heleen M.A., van Ballegooijen, Marjolein, Habbema, J.Dik F.

Volltext

The cost‐effectiveness of breast cancer screening von Van Der Maas, Paul J., De Koning, Harry J., Van Ineveld, B. Martin, Van Oortmarssen, Gerrit J., Habbema, J. Dik F., Lubbe, Koos Th. N., Geerts, Ada T., Collette, Hubertine J. A., Verbeek, André L. M., Hendriks, Jan H. C. L., Rombach, Jan J.

Volltext

Cervical‐cancer screening: Attendance and cost‐effectiveness von Koopmanschap, Marc A., van Oortmarssen, Gerrit J., van Agt, Heleen M. A., van Ballegooijen, Marjolein, Habbema, J. Dik F., Lubbe, Koos Th. N.

Volltext

Skin-reducing Mastectomy with Primary Implant Reconstruction von Siggelkow, W., Lübbe, K., Gade, J., Kölbl, H., Schmidt, M., Böhm, D.

Volltext

Chemotherapy for 70-Year-Old Women with Breast Cancer in Germany: A Survey by the German Breast Group von Barinoff, J., Traut, A., Bauerschlag, D., Bischoff, J., Herr, D., Lübbe, K., Lück, H.-J., Maass, N., Mundhenke, C., Schmidt, M., Schwedler, K., Thill, M., Steffen, J., Loibl, S., von Minckwitz, G.

Volltext

LBA19 A multicenter, randomized, double-blind, phase II study to evaluate the tolerability of an induction dose escalation of everolimus in patients with metastatic breast cancer (... von Loibl, S., Schmidt, M., Lübbe, K., Decker, T., Thill, M., Bauer, L., Müller, V., Link, T., Furlanetto, J., Kümmel, S., Mundhenke, C., Hoffmann, O., Zahn, M-O., Müller, L., Denkert, C., van Mackelenbergh, M., Fasching, P.A., Burchardi, N., Nekljudova, V.

Volltext

170P Long-term survival of breast cancer patients with brain metastases: Subanalysis of the BMBC registry von Riecke, K., Laakmann, E., Neunhöffer, T., Park-Simon, T-W., Weide, R., Schmidt, M., Polasik, A., Puppe, J., Mundhenke, C., Lübbe, K., Hesse, T., Thill, M., Zahm, D-M., Denkert, C., Fehm, T., Nekljudova, V., Rey, J., Loibl, S., Müller, V., Witzel, I.

Volltext

160O Survival analysis of the randomized phase III GeparOcto trial comparing neoadjuvant chemotherapy (NACT) of iddEPC versus weekly paclitaxel, liposomal doxorubicin (plus carbopl... von Schneeweiss, A., Möbus, V., Tesch, H., Klare, P., Denkert, C., Kast, K., Hanusch, C., Link, T., Untch, M., Jackisch, C., Blohmer, J-U., Fasching, P.A., Solbach, C., Huober, J., Rhiem, K.E., Nekljudova, V., Lübbe, K., Loibl, S.

Volltext

149P Predicting prognosis of breast cancer patients with brain metastases in the BMBC registry: Comparison of three different prognostic scores von Riecke, K., Mueller, V., Neunhöffer, T., Weide, R., Schmidt, M., Park-Simon, T-W., Mundhenke, C., Polasik, A., Hesse, T., Lübbe, K., Laakmann, E., Thill, M., Fasching, P., Denkert, C., Fehm, T., Nekljudova, V., Rey, J., Loibl, S., Witzel, I.

Volltext

96O Adjuvant trastuzumab emtansine (T-DM1) vs trastuzumab (T) in patients (pts) with residual invasive disease after neoadjuvant therapy for HER2+ breast cancer: Subgroup analysis... von Loibl, S., Huang, C-S., Mano, M.S., Mamounas, T.P., Geyer, C.E., Untch, M., von Minckwitz, G., Thery, J-C., Schwaner, I., Limentani, S., Loman, N., Lübbe, K., Chang, J.C., Hatschek, T., Tesarowski, D., Boulet, T., Wiese, C., Song, C., Wolmark, N.

Volltext

95MO Characteristics of patients with brain metastases from HER2-positive breast cancer von Laakmann, E., Witzel, I., Neunhöffer, T., Park-Simon, T-W., Weide, R., Riecke, K., Polasik, A., Schmidt, M., Puppe, J., Mundhenke, C., Lübbe, K., Hesse, T., Thill, M., Zahm, D-M., Denkert, C., Fehm, T., Nekljudova, V., Rey, J., Loibl, S., Mueller, V.

Volltext

364TiPAnti-hormonal maintenance treatment with or without the CDK4/6 inhibitor ribociclib after first line chemotherapy in hormone receptor positive/HER2 negative metastatic breast... von Decker, T, Denkert, C, Lübbe, K, Müller, V, Mundhenke, C, Furlanetto, J, Schmidt, M, Thill, M, Tierbach, V, Seither, F, Loibl, S

Volltext

Characteristics and clinical outcome of breast cancer patients with asymptomatic brain metastases von Laakmann, E., Witzel, I., Neunhöffer, T., Weide, R., Schmidt, M., Park-Simon, T.W., Möbus, V., Mundhenke, C., Polasik, A., Lübbe, K., Hesse, T., Riecke, K., Thill, M., Fasching, P.A., Denkert, C., Fehm, T., Nekljudova, V., Rey, J., Loibl, S., Müller, V.

Volltext